Naomi M. Hamburg, MD, MS

Joseph A. Vita, MD Professor, Boston University Chobanian & Avedisian School of Medicine

Biography

Dr. Hamburg is the inaugural Joseph A. Vita Professor of Medicine, Chief of the Vascular Biology Section, interim Director of the Whitaker Cardiovascular Institute at Boston University School of Medicine and an Attending in the Cardiovascular Medicine Section at Boston Medical Center. Dr. Hamburg is a recognized expert in the field of Vascular Medicine and the clinical translation of Vascular Biology. Her research work seeks to understand approaches to restore vascular health in patients with cardiometabolic disorders, peripheral artery disease, and to evaluate the impact of novel tobacco products and long COVID. Her work has been continuously funded by the National Institutes of Health and foundations since 2006. Dr. Hamburg has held multiple leadership positions in the field of Vascular Medicine including as the Chair of the Peripheral Vascular Disease Council of the American Heart Association, and as a member of the Board of the Society of Vascular Medicine, the American Society of Echocardiography and the Vascular Testing Division of the Intersocietal Accreditation Commission. She co-Chaired the Advanced Training Statement for Vascular Medicine from the American College of Cardiology and the Society of Vascular Medicine. Dr. Hamburg has authored more than 150 scientific papers in the peer reviewed literature and has served on guideline writing committees. She is a past Associate Editor of the journal Vascular Medicine, and current Associate Editor for Circulation Research. She is passionate about improving the care of vascular diseases and reducing the burden of PAD through education. When not working, she enjoys spending time in the mountains hiking and skiing with her husband and two teenage sons.

Publications

  • Published 7/2/2026

    Ko D, Evans PT, Park CM, Kato B, Van Over M, Conte MS, Cziraky M, Shah SJ, Pande AN, Hamburg NM, Rosenfield K, Menard MT, Farber A, Kim DH. Frailty and the efficacy and safety of surgical versus endovascular revascularization: post-hoc analysis of the BEST-CLI trial. Br J Surg. 2026 Jul 02; 113(7). PMID: 42227206.

    Read at: PubMed

  • Published 6/16/2026

    Martins KPMP, Barreto SM, Camelo LV, Menezes ST, Hamburg NM, Diniz MFHS, Ribeiro ALP, Brant LCC. Endothelial Function Is Associated With Incident Diabetes Mellitus: The ELSA-Brasil Cohort Study. Diabetes Obes Metab. 2026 Jun 16. PMID: 42303277.

    Read at: PubMed

  • Published 6/1/2026

    Garshick MS, Schlamp F, Boothman I, Barrett TJ, Kazatsker F, Westby G, Xia Y, Smilowitz NR, Jelic S, Hamburg NM, Goldberg IJ, Berger JS. Validation of Brachial Vein Endothelial Transcriptomics to Assess the Coronary Vasculature. Circ Res. 2026 Jul 06; 139(2):e328283. PMID: 42220240.

    Read at: PubMed

  • Published 5/1/2026

    Tao Q, Han J, Ang TFA, Hou L, Liu C, Murabito JM, Lunetta KL, Mez J, Alosco ML, Stein TD, Zhang X, Au R, Farrer L, Palmisano JN, Hamburg NM, Qiu WQ. Peripheral vascular function, including endothelium-dependent measures, and dementia risk: The Framingham Heart Study. Alzheimers Dement. 2026 May; 22(5):e71396. PMID: 42050369.

    Read at: PubMed

  • Published 3/19/2026

    Korzinski TJ, Prescott BR, Hamel-Sellman DJ, Xanthakis V, Cooper LL, Hamburg NM, Tsao CW, Benjamin EJ, Vasan RS, Mitchell GF. Development and Validation of the AI-HeartAge Model in Framingham and UK Biobank. Hypertension. 2026 Jun; 83(6):e26209. PMID: 41853838.

    Read at: PubMed

View All 254 Publications:   View Full Profile in BUMC

Other Positions

  • Section Chief, Medicine
    Boston University Chobanian & Avedisian School of Medicine
  • Investigator
    Framingham Heart Study
  • Interim Director, Whitaker Cardiovascular Institute
    Boston University
  • Member, Evans Center for Interdisciplinary Biomedical Research
    Boston University

Websites

Education

  • Harvard Medical School, MD
  • Harvard University, AB

View all profiles